AHR
Income statement / Annual
Last year (2024), American Healthcare REIT, Inc.'s total revenue was $2.07 B,
an increase of 11.38% from the previous year.
In 2024, American Healthcare REIT, Inc.'s net income was -$37.81 M.
See American Healthcare REIT, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$2.07 B |
$1.86 B |
$1.62 B |
$1.27 B |
$1.19 B |
$120.77 M |
$84.35 M |
$46.87 M |
$3.10 M |
| Cost of Revenue |
$1.65 B
|
$1.50 B
|
$1.28 B
|
$1.03 B
|
$993.73 M
|
$102.29 M
|
$74.08 M
|
$25.02 M
|
$3.00 M
|
| Gross Profit |
$416.78 M
|
$356.83 M
|
$335.97 M
|
$235.11 M
|
$195.39 M
|
$18.48 M
|
$10.28 M
|
$21.85 M
|
$93,000.00
|
| Gross Profit Ratio |
0.2
|
0.19
|
-0.09
|
0.19
|
0.1
|
0.15
|
0.12
|
0.47
|
0.03
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$0.16
|
-$0.10
|
$0.30
|
-$2.05
|
| General & Administrative Expenses |
$100.80 M
|
$104.99 M
|
$103.10 M
|
$81.92 M
|
$59.31 M
|
$29.75 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$100.80 M
|
$104.99 M
|
$103.10 M
|
$81.92 M
|
$59.31 M
|
$29.75 M
|
-$0.10
|
$0.30
|
-$2.05
|
| Other Expenses |
$179.19 M
|
$175.13 M
|
$142.28 M
|
$116.24 M
|
$43.68 M
|
-$17.72 M
|
-$9.68 M
|
-$3.35 M
|
-$5.28 M
|
| Operating Expenses |
$279.99 M
|
$280.11 M
|
$245.38 M
|
$198.16 M
|
$102.98 M
|
$140.08 M
|
-$9.68 M
|
-$3.35 M
|
-$5.28 M
|
| Cost And Expenses |
$1.93 B
|
$1.78 B
|
$1.53 B
|
$1.23 B
|
$1.10 B
|
$121.91 M
|
$64.39 M
|
$21.67 M
|
-$2.28 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$127.73 M
|
$163.19 M
|
$105.96 M
|
$80.94 M
|
$71.28 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$221.64 M
|
$237.30 M
|
$200.60 M
|
$157.38 M
|
$129.65 M
|
$45.63 M
|
$83.25 M
|
$29.36 M
|
$4.19 M
|
| EBITDA |
$315.48 M |
$324.26 M |
$233.76 M |
$186.00 M |
$206.71 M |
$44.49 M |
$75.77 M |
$1,000.00 |
-$3.23 M |
| EBITDA Ratio |
0.01
|
0.17
|
0.19
|
0.15
|
0.18
|
0.37
|
0.9
|
0
|
-1.04
|
| Operating Income Ratio |
0.2
|
0.13
|
0.27
|
0.1
|
0.08
|
-0.01
|
0.39
|
0.29
|
0.4
|
| Total Other Income/Expenses Net |
-$170.67 M
|
-$152.94 M
|
-$163.39 M
|
-$89.26 M
|
-$86.63 M
|
-$17.72 M
|
-$18.92 M
|
$17.51 M
|
-$1.07 M
|
| Income Before Tax |
-$33.89 M
|
-$76.22 M
|
-$72.80 M
|
-$52.31 M
|
$5.79 M
|
-$18.86 M
|
$33.76 M
|
$31.14 M
|
$183,000.00
|
| Income Before Tax Ratio |
-0.02
|
-0.04
|
0.16
|
0.14
|
0.15
|
-0.16
|
0.4
|
0.66
|
0.06
|
| Income Tax Expense |
$1.71 M
|
$663,000.00
|
$586,000.00
|
$956,000.00
|
-$3.08 M
|
-$8,000.00
|
$1.10 M
|
$17.51 M
|
-$1.07 M
|
| Net Income |
-$37.81 M
|
-$71.47 M
|
-$81.30 M
|
-$47.79 M
|
$2.16 M
|
-$18.77 M
|
-$8.58 M
|
$14.16 M
|
-$6.35 M
|
| Net Income Ratio |
-0.02
|
-0.04
|
-0.04
|
-0.04
|
0
|
-0.16
|
-0.1
|
0.3
|
-2.05
|
| EPS |
-0.29 |
-1.08 |
-1.1 |
-0.79 |
0.0876 |
-0.41 |
-0.17 |
0.29 |
-0.13 |
| EPS Diluted |
-0.29 |
-1.08 |
-1.1 |
-0.79 |
0.0876 |
-0.41 |
-0.17 |
0.29 |
-0.13 |
| Weighted Average Shares Out |
$130.64 M
|
$66.05 M
|
$66.21 M
|
$66.21 M
|
$66.05 M
|
$45.48 M
|
$49.99 M
|
$49.56 M
|
$48.55 M
|
| Weighted Average Shares Out Diluted |
$130.64 M
|
$66.05 M
|
$66.21 M
|
$66.21 M
|
$66.05 M
|
$45.48 M
|
$49.99 M
|
$49.56 M
|
$48.55 M
|
| Link |
|
|
|
|
|
|
|
|
|
